A histopathological diagnostic marker for human spinal astrocytoma: Expression of glial fibrillary acidic protein-δ

Dong Hwa Heo, Se Hoon Kim, Kyung Moo Yang, Yong Jun Cho, Keung Nyun Kim, Do Heum Yoon, Tae Cheon Kang

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Although histopathological diagnosis of spinal cord astrocytomas is important for postoperative treatment planning and prognosis, there is a lack of reliable immunohistochemical markers. The purpose of our study was to assess the expression pattern of GFAP-δ in spinal cord astrocytomas in human patients and to evaluate the utility of GFAP-δ as an immunohistochemical diagnostic marker. A total of 22 patients with spinal cord astrocytic tumors were included in this study. Patients were classified according to the WHO designation of human astrocytic tumors; three patients had grade 1 astrocytomas, 14 had grade 2, and five had Grade 3. Normal control spinal cord tissues were obtained at autopsy from the cervical spinal cords of ten patients with no history of cervical trauma or neurological disease. We evaluated BRAF, IDH1, GFAP, and GFAP-δ immunoreactivity in control tissues and astrocytomas. In normal control tissues, GFAP immunoreactivity was detected in astrocytes whereas GFAP-δ immunoreactivity was observed in very few astrocytes adjacent to the subpial layer of the spinal cord. GFAP-δ immunoreactivity was significantly correlated with spinal cord astrocytoma grade in astrocytomas compared to that in normal control tissues. The optical density of GFAP-δ increased significantly with astrocytoma grade (correlation coefficient, R 2 = 0.680). Also, BRAF and IDH1 immunoreactivity were detected in astrocytoma. We suggest that GFAP-δ may be an additional, reliable histopathological diagnostic marker for spinal cord astrocytomas.

Original languageEnglish
Pages (from-to)45-52
Number of pages8
JournalJournal of Neuro-Oncology
Volume108
Issue number1
DOIs
Publication statusPublished - 2012 May 1

Fingerprint

Glial Fibrillary Acidic Protein
Astrocytoma
Spinal Cord
Astrocytes
Spinal Cord Neoplasms
Autopsy
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Heo, Dong Hwa ; Kim, Se Hoon ; Yang, Kyung Moo ; Cho, Yong Jun ; Kim, Keung Nyun ; Yoon, Do Heum ; Kang, Tae Cheon. / A histopathological diagnostic marker for human spinal astrocytoma : Expression of glial fibrillary acidic protein-δ. In: Journal of Neuro-Oncology. 2012 ; Vol. 108, No. 1. pp. 45-52.
@article{f85612cd4a604f84a55d218db88dc3e1,
title = "A histopathological diagnostic marker for human spinal astrocytoma: Expression of glial fibrillary acidic protein-δ",
abstract = "Although histopathological diagnosis of spinal cord astrocytomas is important for postoperative treatment planning and prognosis, there is a lack of reliable immunohistochemical markers. The purpose of our study was to assess the expression pattern of GFAP-δ in spinal cord astrocytomas in human patients and to evaluate the utility of GFAP-δ as an immunohistochemical diagnostic marker. A total of 22 patients with spinal cord astrocytic tumors were included in this study. Patients were classified according to the WHO designation of human astrocytic tumors; three patients had grade 1 astrocytomas, 14 had grade 2, and five had Grade 3. Normal control spinal cord tissues were obtained at autopsy from the cervical spinal cords of ten patients with no history of cervical trauma or neurological disease. We evaluated BRAF, IDH1, GFAP, and GFAP-δ immunoreactivity in control tissues and astrocytomas. In normal control tissues, GFAP immunoreactivity was detected in astrocytes whereas GFAP-δ immunoreactivity was observed in very few astrocytes adjacent to the subpial layer of the spinal cord. GFAP-δ immunoreactivity was significantly correlated with spinal cord astrocytoma grade in astrocytomas compared to that in normal control tissues. The optical density of GFAP-δ increased significantly with astrocytoma grade (correlation coefficient, R 2 = 0.680). Also, BRAF and IDH1 immunoreactivity were detected in astrocytoma. We suggest that GFAP-δ may be an additional, reliable histopathological diagnostic marker for spinal cord astrocytomas.",
author = "Heo, {Dong Hwa} and Kim, {Se Hoon} and Yang, {Kyung Moo} and Cho, {Yong Jun} and Kim, {Keung Nyun} and Yoon, {Do Heum} and Kang, {Tae Cheon}",
year = "2012",
month = "5",
day = "1",
doi = "10.1007/s11060-012-0801-z",
language = "English",
volume = "108",
pages = "45--52",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

A histopathological diagnostic marker for human spinal astrocytoma : Expression of glial fibrillary acidic protein-δ. / Heo, Dong Hwa; Kim, Se Hoon; Yang, Kyung Moo; Cho, Yong Jun; Kim, Keung Nyun; Yoon, Do Heum; Kang, Tae Cheon.

In: Journal of Neuro-Oncology, Vol. 108, No. 1, 01.05.2012, p. 45-52.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A histopathological diagnostic marker for human spinal astrocytoma

T2 - Expression of glial fibrillary acidic protein-δ

AU - Heo, Dong Hwa

AU - Kim, Se Hoon

AU - Yang, Kyung Moo

AU - Cho, Yong Jun

AU - Kim, Keung Nyun

AU - Yoon, Do Heum

AU - Kang, Tae Cheon

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Although histopathological diagnosis of spinal cord astrocytomas is important for postoperative treatment planning and prognosis, there is a lack of reliable immunohistochemical markers. The purpose of our study was to assess the expression pattern of GFAP-δ in spinal cord astrocytomas in human patients and to evaluate the utility of GFAP-δ as an immunohistochemical diagnostic marker. A total of 22 patients with spinal cord astrocytic tumors were included in this study. Patients were classified according to the WHO designation of human astrocytic tumors; three patients had grade 1 astrocytomas, 14 had grade 2, and five had Grade 3. Normal control spinal cord tissues were obtained at autopsy from the cervical spinal cords of ten patients with no history of cervical trauma or neurological disease. We evaluated BRAF, IDH1, GFAP, and GFAP-δ immunoreactivity in control tissues and astrocytomas. In normal control tissues, GFAP immunoreactivity was detected in astrocytes whereas GFAP-δ immunoreactivity was observed in very few astrocytes adjacent to the subpial layer of the spinal cord. GFAP-δ immunoreactivity was significantly correlated with spinal cord astrocytoma grade in astrocytomas compared to that in normal control tissues. The optical density of GFAP-δ increased significantly with astrocytoma grade (correlation coefficient, R 2 = 0.680). Also, BRAF and IDH1 immunoreactivity were detected in astrocytoma. We suggest that GFAP-δ may be an additional, reliable histopathological diagnostic marker for spinal cord astrocytomas.

AB - Although histopathological diagnosis of spinal cord astrocytomas is important for postoperative treatment planning and prognosis, there is a lack of reliable immunohistochemical markers. The purpose of our study was to assess the expression pattern of GFAP-δ in spinal cord astrocytomas in human patients and to evaluate the utility of GFAP-δ as an immunohistochemical diagnostic marker. A total of 22 patients with spinal cord astrocytic tumors were included in this study. Patients were classified according to the WHO designation of human astrocytic tumors; three patients had grade 1 astrocytomas, 14 had grade 2, and five had Grade 3. Normal control spinal cord tissues were obtained at autopsy from the cervical spinal cords of ten patients with no history of cervical trauma or neurological disease. We evaluated BRAF, IDH1, GFAP, and GFAP-δ immunoreactivity in control tissues and astrocytomas. In normal control tissues, GFAP immunoreactivity was detected in astrocytes whereas GFAP-δ immunoreactivity was observed in very few astrocytes adjacent to the subpial layer of the spinal cord. GFAP-δ immunoreactivity was significantly correlated with spinal cord astrocytoma grade in astrocytomas compared to that in normal control tissues. The optical density of GFAP-δ increased significantly with astrocytoma grade (correlation coefficient, R 2 = 0.680). Also, BRAF and IDH1 immunoreactivity were detected in astrocytoma. We suggest that GFAP-δ may be an additional, reliable histopathological diagnostic marker for spinal cord astrocytomas.

UR - http://www.scopus.com/inward/record.url?scp=84862798136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862798136&partnerID=8YFLogxK

U2 - 10.1007/s11060-012-0801-z

DO - 10.1007/s11060-012-0801-z

M3 - Article

C2 - 22318658

AN - SCOPUS:84862798136

VL - 108

SP - 45

EP - 52

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -